phenprocoumon,apixaban
pfizer,bms
['apixaban']
small study showing reduced-dose apixaban (2.5 mg bid) had similar bleeding and outcomes as vit k antagonist (vka). larger trials would be good - but this is supportive of using that lower dose. 
Cardiologist, CV Innovation, Brigham and Women's Hosp, Professor of Medicine, Harvard Medical School, CPC Research.   #TeamPete